Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma

Annals of Surgical Oncology

Volumn 21, Issue 8, 2014, Pages 2684-2698

  Kim, Younjoo ^a   Kim, Myeong Ok ^b   Shin, Jin Sun ^a   Park, Sun Hoo ^a   Kim, Sang Bum ^a   Kim, Jin ^a   Park, Su Cheol ^a   Han, Chul Ju ^a   Ryu, Ji Kon ^c   Yoon, Yong Bum ^d   Kim, Yong Tae ^c  

^a Korea Cancer Center Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d National Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPAMINE; DIMETHYL SULFOXIDE; GEMCITABINE; INTERLEUKIN 6; KERATINOCYTE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VISMODEGIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BILE DUCT CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CAPILLARY DENSITY; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; OVERALL SURVIVAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STELLATE CELL; TREATMENT DURATION; TUMOR NECROSIS; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BILE DUCT TUMOR; CELL MOTION; DRUG SCREENING; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; INTRAHEPATIC BILE DUCT; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; TUMOR CELL CULTURE; TUMOR INVASION;

ANIMALS; APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CHOLANGIOCARCINOMA; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; HEDGEHOG PROTEINS; HEPATIC STELLATE CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84905120618     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3531-y     Document Type: Article

References (36)

1. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273-81.
2. Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev. 2008;22:2454-72.
3. Scales SJ, de Sauvage FJ. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci. 2009;30:303-12.
4. Jung Y, McCall SJ, Li YX, Diehl AM. Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis. Hepatology. 2007;45:1091-6. (Pubitemid 46775770)
5. Omenetti A, Diehl AM. Hedgehog signaling in cholangiocytes. Curr Opin Gastroenterol. 2011;27:268-75.
6. Kurita S, Mott JL, Almada LL, et al. GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis. Oncogene. 2010;29:4848-58.
7. Kurita S, Mott JL, Cazanave SC, et al. Hedgehog inhibition promotes a switch from type II to type I cell death receptor signaling in cancer cells. PLoS One. 2011;6:e18330.
8. Jinawath A, Akiyama Y, Sripa B, Yuasa Y. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells. J Cancer Res Clin Oncol. 2007;133:271-8.
9. Yauch RL, Gould SE, Scales SJ, et al. A paracrine requirement for hedgehog signalling in cancer. Nature. 2008;455:406-10.
10. Mott JL, Kurita S, Cazanave SC, Bronk SF, Werneburg NW, Fernandez-Zapico ME. Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem. 2010;110:1155-64.
11. El Khatib M, Kalnytska A, Palagani V, et al. Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma. Hepatology. 2013;57:1035-45.
12. Sirica AE. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;9:44-54.
13. Sirica AE, Campbell DJ, Dumur CI. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol. 2011;27:276-84.
14. Fingas CD, Bronk SF, Werneburg NW, et al. Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells. Hepatology. 2011;54:2076-88.
15. Okabe H, Beppu T, Hayashi H, et al. Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16:2555-64.
16. Okabe H, Beppu T, Hayashi H, et al. Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells. Ann Surg Oncol. 2011;18:1175-84.
17. Choi SS, Omenetti A, Witek RP, et al. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2009;297:G1093-106.
18. Chen Y, Choi SS, Michelotti GA, et al. Hedgehog controls hepatic stellate cell fate by regulating metabolism. Gastroenterology. 2012;143:1319-29.e1-11.
19. Michelotti GA, Xie G, Swiderska M, et al. Smoothened is a master regulator of adult liver repair. J Clin Invest. 2013;123:2380-94.
20. Theunissen JW, de Sauvage FJ. Paracrine Hedgehog signaling in cancer. Cancer Res. 2009;69:6007-10.
21. Chen W, Tang T, Eastham-Anderson J, et al. Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells. Proc Natl Acad Sci USA. 2011;108:9589-94.
22. O'Toole SA, Machalek DA, Shearer RF, et al. Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer. Cancer Res. 2011;71:4002-14.
23. Olive KP, Jacobetz MA, Davidson CJ, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324:1457-61.
24. Xu L, Hui AY, Albanis E, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut. 2005;54:142-51. (Pubitemid 40007234)
25. Lipinski RJ, Hutson PR, Hannam PW, et al. Dose- and route-dependent teratogenicity, toxicity, and pharmacokinetic profiles of the hedgehog signaling antagonist cyclopamine in the mouse. Toxicol Sci. 2008;104:189-97. (Pubitemid 351859041)
26. Ng JM, Curran T. The Hedgehog's tale: developing strategies for targeting cancer. Nat Rev Cancer. 2011;11:493-501.
27. Saze Z, Terashima M, Kogure M, Ohsuka F, Suzuki H, Gotoh M. Activation of the sonic hedgehog pathway and its prognostic impact in patients with gastric cancer. Dig Surg. 2012;29:115-23.
28. Li Q, Zhang Y, Zhan H, Yuan Z, Lu P, Zhan L, et al. The Hedgehog signalling pathway and its prognostic impact in human gliomas. ANZ J Surg. 2011;81:440-5.
29. Ishiyama A, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, et al. PTCH gene expression as a potential marker for esophageal squamous cell carcinoma. Anticancer Res. 2006;26:195-8. (Pubitemid 43206078)
30. Kim YJ, Park SB, Park JY, Park SW, Chung JB, Song SY, et al. The sonic hedgehog pathway as a treatment target for extrahepatic biliary tract cancer. Mol Med Rep. 2012;5:12-6.
31. Torti D, Trusolino L. Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils. EMBO Mol Med. 2011;3:623-36.
32. Chan IS, Guy CD, Chen Y, et al. Paracrine Hedgehog signaling drives metabolic changes in hepatocellular carcinoma. Cancer Res. 2012;72:6344-50.
33. Omenetti A, Bass LM, Anders RA, et al. Hedgehog activity, epithelial-mesenchymal transitions, and biliary dysmorphogenesis in biliary atresia. Hepatology. 2011;53:1246-58.
34. Omenetti A, Syn WK, Jung Y, et al. Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology. 2009;50:518-27.
35. Syn WK, Agboola KM, Swiderska M, et al. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut. 2012;61:1323-9.
36. Chuaysri C, Thuwajit P, Paupairoj A, Chau-In S, Suthiphongchai T, Thuwajit C. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. Oncol Rep. 2009;21:957-69.